15.94USDMkt Cap: 4.51B USDP/E: —Last update: 2026-05-21
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare usin…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap4.51B USD
Enterprise Value4.11B USD
Revenue (TTM)907.29M USD
Gross Profit539.17M USD
Net Income (TTM)-68.09M USD
Revenue/Share3.963 USD
Last Price15.94 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.8K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)42.78
PEG—
EV/EBITDA31.89
EV/Revenue4.53
P/S4.97
P/B7.59
EPS (TTM)-2.76
EPS (Forward)0.37
52W Range
15.1779% of range16.14
52W High16.14 USD
52W Low15.17 USD
Profitability
Gross Margin66.40%
Oper. Margin2.44%
EBITDA Margin14.22%
Profit Margin-8.38%
ROE-11.79%
ROA-6.05%
Growth
Revenue Growth78.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF83.16M USD
CapEx (TTM)16.26M USD
FCF Margin11.25%
FCF Yield2.26%
Net Debt-392.50M USD
Net Debt/EBITDA-3.04
Balance Sheet
Debt/Equity0.74
Current Ratio7.05
Quick Ratio6.35
Book Value/Sh2.100 USD
Cash/Share2.913 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)28.00 USD
Target Range21.00 USD – 36.00 USD
# Analysts13
Ownership
Shares Out.282.68M
Float103.51M
Insiders48.51%
Institutions56.58%
Short Interest
Short Ratio7.0d
Short % Float11.05%
Short % Out.4.50%
Shares Short12.73M
Short (prev mo.)10.29M
Technical
SMA 5018.38 (-13.3%)
SMA 20025.65 (-37.8%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)2.37M
Avg Vol (10d)4.39M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—